Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells

Brain Research Bulletin

Volumn 49, Issue 4, 1999, Pages 291-295

  Zavosh, Aryana ^a   Schaefer, Jonathan ^b   Ferrel, Anne ^a,b,c   Figlewicz, Dianne P ^a,b,c  

^a Depts of Department of Psychology   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Desipramine; Neuroblastoma; Norepinephrine transporter; Quantitative RTPCR

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; MESSENGER RNA; NISOXETINE; NORADRENALIN;

ARTICLE; HUMAN; HUMAN CELL; LOCUS CERULEUS; NEUROBLASTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPTIC MEMBRANE;

ADRENERGIC UPTAKE INHIBITORS; CARRIER PROTEINS; DESIPRAMINE; FLUOXETINE; HUMANS; NEUROBLASTOMA; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS; TUMOR CELLS, CULTURED;

EID: 0032814038     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00063-5     Document Type: Article

References (18)

1. Barker E.L., Blakely R.D. Norepinephrine and serotonin transporters. Bloom F.E., Kupfer D.J. Psychopharmacology. A fourth generation of progress. 1995;321-333 Raven Press, New York.
2. Bauer M.E., Tejani-Butt S.M. Effects of repeated administration of desipramine or electroconvulsive shock on norepinephrine uptake sites measured by [3H]nisoxetine autoradiography. Brain Res. 582:1992;208-214.
3. Biedler J.L., Roffler-Tarlov S., Schachner M., Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38:1978;3751-3757.
4. Ciccarone V., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A. Phenotypic diversification in human neuroblastoma cells Expression of distinct neural crest lineages . Cancer Res. 49:1989;219-225.
5. Dostal D.E., Rothblum K.N., Baker K.M. An improved method for absolute quantification of mRNA using multiplex polymerase chain reaction Determination of renin and angiotensinogen mRNA levels in various tissues . Anal. Biochem. 223:1994;239-250.
6. Eshleman A.J., Janowsky A. The norepinephrine transporter of SK-N-SH cells Modulation of function and ligand binding properties by activators of protein kinase C . Soc. Neurosci. Abstr. 20:1994;924.
7. Hentze M.W., Kuhn L.C. Molecular control of vertebrate iron metabolism mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress . Proc. Natl. Acad. Sci. U.S.A. 93:1996;8175-8182.
8. Innis M.A. PCR protocols A guide to methods and applications . 1989;Academic Press, San Diego.
9. Oswald I., Brezinova V., Dunleavy D.L.F. On the slowness of action of tricyclic antidepressant drugs. Br. J. Psychiatry. 120:1972;673-677.
10. Oyarce A.M., Fleming P.J. Multiple forms of human dopamine B-hydroxylase in SH-SY5Y neuroblastoma cells. Arch. Biochem. Biophys. 290:1991;503-510.
11. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 350:1991;350-354.
12. Padbury J.F., Worrell L.A., Nguyen T., Tseng Y.T., McGonnigal B., Stabila J. Pharmacologic regulation of the norepinephrine transporter (NET) in SK-N-SH and primary placental cells. Soc. Neurosci. Abstr. 23:1997;694.
13. Potgens A.J., Lubsen N.H., vanAltena G., Schoenmakers J.G., Ruiter D.J., deWaal R.M. Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay. Thromb. Haemost. 71:1994;208-213.
14. Ross S.B., Renyi A.L. Inhibition of the uptake of tritiated catecholamines by antidepressants and related agents. Eur. J. Pharmacol. 2:1967;181-186.
15. Ross S.B., Renyi A.L., Ogren S.O. A comparison of the inhibiting activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices. Life Sci. 10:1971;1267-1277.
16. Szot P., Ashleigh E.A., Kohen R., Petrie E., Dorsa D.M., Veith R. Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment. Brain Res. 618:1993;308-312.
17. Zhu M.-Y., Ordway G.A. Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors. J. Neurochem. 68:1997;134-141.
18. Zhu M.-Y., Blakely R.D., Apparsundaram S., Ordway G.A. Down-regulation of the human norepinephrine transporter in intact 293-hNET cells exposed to desipramine. J. Neurochem. 70:1998;1547-1555.